JP

Tomomi Ota

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomomi Ota. Retrieved from https://idiyas.com/inventor/tomomi-ota-ll2wzfnf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Tomomi Ota - Innovator in Amino Compounds

Introduction

Tomomi Ota is a notable inventor based in Japan, recognized for her contributions to the field of medicinal chemistry. She has developed innovative compounds that have potential therapeutic applications. Her work focuses on amino compounds and their role as angiotensin IV receptor agonists.

Latest Patents

Tomomi Ota holds a patent for "Amino Compounds And Angiotensin IV Receptor Agonists." This invention provides an aminocompound represented by a specific formula, which includes various substituents and groups that enhance its medicinal properties. The compound is particularly useful as a therapeutic drug for various diseases where angiotensin IV plays a significant role, such as renal blood flow acceleration and cerebral vasodilation.

Career Highlights

Ota is currently employed at Cogstate, Ltd., where she continues her research and development in the field of medicinal chemistry. Her work has contributed to advancements in understanding the therapeutic potential of amino compounds.

Collaborations

Tomomi Ota has collaborated with esteemed colleagues, including Takeo Kobori and Kenichi Goda, to further her research and development efforts. These collaborations have enhanced the scope and impact of her work in the field.

Conclusion

Tomomi Ota is a pioneering inventor whose work on amino compounds has the potential to lead to significant advancements in therapeutic applications. Her contributions to medicinal chemistry are noteworthy and continue to influence the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…